Penn Medicine Co-Investment Program

company

About

Penn Medicine Co-Investment Program makes investments in faculty-driven cell therapy, gene therapy, and connected health companies

  • 10001 - max

Highlights

Details

Industries
Biopharma,Biotechnology,Health Care,Life Science
Number Of Employee
10001 - max
Operating Status
Active
Investor Type
Venture Capital

Investments

Number of Investments
Number of Lead Investments
3
0
Penn Medicine Co-Investment Program has made 3 investments. Their most recent investment was on Sep 21, 2022, when Carisma Therapeutics raised $30M.
Date Company Name
Round Money Raised Industry Lead Investor
Series C $30M Biotechnology
Series B $12M Biotechnology
Series A $53M Biotechnology